NEW YORK, Nov. 16, 2017 /PRNewswire/ --

Acorda Therapeutics, Inc. (ACOR)

Lifshitz & Miller announces an investigation on behalf of ACOR investors concerning whether ACOR issued false and misleading statements about its Phase 3 trial of tozadenant after 5 patient deaths.

If you are an ACOR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Alkermes plc (ALKS)

Lifshitz & Miller announces an investigation on behalf of ALKS investors concerning whether ALKS issued false and misleading statements about its sales practices for its opioid-addiction-treatment Vivitrol.

If you are an ALKS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ASB Financial Corp. (ASBN)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of ASBN to Peoples Bancorp in which ASBN shareholders will receive for each ASBN share either $20.00 in cash or 0.592 shares of Peoples Bancorp.

If you are an ASBN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

CalAtlantic Group (CAA)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of CAA to Lennar Corporation in which CAA shareholders will receive either $48.26 in cash, 0.885 Lennar shares, or a combination of both, for each share of CAA owned.

If you are a CAA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Capella Education Company (CPLA)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of CPLA to Strayer Education in which CPLA shareholders will receive 0.875 Strayer shares for each CPLA share.

If you are a CPLA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

INC Research Holdings, Inc. (INCR)

Lifshitz & Miller announces an investigation on behalf of INCR investors concerning whether INCR issued false and misleading statements related to the inventive Health merger.

If you are an INCR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

YuMe, Inc. (YUME)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of YUME to RhythmOne affiliates in which YUME shareholders will receive $1.70 in cash and 7.325 RhythmOne shares for each YUME share.

If you are a YUME investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780
Facsimile: 516-280-7376
Email:
info@jlclasslaw.com

View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-acorda-therapeutics-inc-alkermes-plc-asb-financial-corp-calatlantic-group-capella-education-company-inc-research-holdings-inc-and-yume-inc-300558277.html

SOURCE Lifshitz & Miller